Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Aarón Molina-Pérez"'
1
Akademický článek
New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept
Autor: Mariana P. Miranda-Hernández, Carlos A. López-Morales, Francisco C. Perdomo-Abúndez, Rodolfo D. Salazar-Flores, Nancy D. Ramírez-Ibanez, Nestor O. Pérez, Aarón Molina-Pérez, Jorge Revilla-Beltri, Luis F. Flores-Ortiz, Emilio Medina-Rivero
Publikováno v: Journal of Immunology Research, Vol 2016 (2016)
Etanercept is a recombinant fusion protein approved for the treatment of TNF-α mediated diseases such as rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, and ankylosing spondylitis. Herein, we present an evaluation of the physicochemical a
Externí odkaz: https://doaj.org/article/79483363e6cb43799983c15853ffc4be
Zobrazit plný text záznamu
2
Akademický článek
Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
Autor: Mariana P. Miranda-Hernández, Carlos A. López-Morales, Nancy D. Ramírez-Ibáñez, Nelly Piña-Lara, Nestor O. Pérez, Aarón Molina-Pérez, Jorge Revilla-Beltri, Luis F. Flores-Ortiz, Emilio Medina-Rivero
Publikováno v: Journal of Immunology Research, Vol 2015 (2015)
Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds speci
Externí odkaz: https://doaj.org/article/1a8f5c046de84cd6b293245a82d39fb9
Zobrazit plný text záznamu
3
Comparative Bioavailability of Metformin Hydrochloride Oral Solution Versus Metformin Hydrochloride Tablets in Fasting Mexican Healthy Volunteers
Autor: Ana Gabriela Amador-Hernández, Marco Vinicio Gómez-Meza, Eduardo Javier Tamez de la O, Aarón Molina-Pérez, Jorge González-Canudas, Christian Tadeo Badillo-Castañeda, Lourdes Garza-Ocañas, Yulia Romero-Antonio
Publikováno v: Advances in Therapy. 36:407-415
Metformin tablets may be challenging to swallow not only for those patients with dysphagia but also for children and the elderly. A metformin solution was developed for easier administration and flexible dose adjustment mantained with the same bioava
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9244bef003f2d82db27100f53a204a07
https://doi.org/10.1007/s12325-018-0853-3
Zobrazit plný text záznamu
6
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization
Autor: Nelly Piña-Lara, Alejandro Ruiz-Argüelles, Larisa Estrada-Marín, Luis F. Flores-Ortiz, Carlos A. López-Morales, Francisco C. Perdomo-Abúndez, Aarón Molina-Pérez, Emilio Medina-Rivero, Mariana P. Miranda-Hernández, Jorge Revilla-Beltri, Néstor O. Pérez
Publikováno v: BioMed Research International
BioMed Research International, Vol 2015 (2015)
Comparability between a biosimilar and its reference product requires the evaluation of critical quality attributes that may impact on its pharmacological response. Herein we present a physicochemical characterization of a biosimilar trastuzumab focu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7581cb778c17daf936d65a5125d1943
https://pubmed.ncbi.nlm.nih.gov/26682224
Zobrazit plný text záznamu
7
Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
Autor: Emilio Medina-Rivero, Jorge Revilla-Beltri, Mariana P. Miranda-Hernández, Nancy D. Ramírez-Ibanez, Nelly Piña-Lara, Luis F. Flores-Ortiz, Néstor O. Pérez, Carlos A. López-Morales, Aarón Molina-Pérez
Publikováno v: Journal of Immunology Research, Vol 2015 (2015)
Journal of Immunology Research
Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds speci
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2301bb20acf83f50360df6762fbe8f07
https://doaj.org/article/1a8f5c046de84cd6b293245a82d39fb9
Zobrazit plný text záznamu
8
Eritropoyetina recombinante humana en pacientes con enfermedad renal crónica en etapa de prediálisis
Autor: María del Carmen Popoca Martínez, Iván Henríquez Moreu, Antonio Méndez Durán, Jorge Revilla Beltri, Aarón Molina Pérez
Publikováno v: Instituto Mexicano del Seguro Social
IMSS
Redalyc-IMSS
Objetivo: evaluar el efecto de la eritropoyetina recombinante humana en pacientes con anemia y enfermedad renal crónica, en etapa de prediálisis, y su repercusión en la calidad de vida. Material y métodos: se seleccionaron 20 pacientes con enferm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::6ccc255a63d5c4895e893b5d02d99585
http://www.redalyc.org/articulo.oa?id=47311448004
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje